Companies/Rgenta Therapeutics

Rgenta Therapeutics

HealthcareBiotech & Pharma

HQ: Woburn, United States

Investors: 1

Develops small molecule drugs targeting RNA-mediated diseases

Investors (1)

Fund	Status	Entry Date	Stage	Source
EQT	Exited	-	-	Website

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.